Abstract
Hepatocellular carcinoma (HCC) is one of the most malignant cancers with high morbidity and mortality. Nowadays, AFP-negative hepatocellular carcinoma (AFP-NHCC) has been found in many HCC patients and AFP analysis can’t be used to screen HCC in these cases. In this study, we have examined the expression patterns of pre-albumin (PA), fibrinogen, D-Dimer and their clinical significance in AFP-NHCC. We recruited 214 AFP-NHCC patients and 210 controls in the study. PA, fibrinogen and D-Dimer levels were detected by turbidimetry, clauss and immunoturbidimetry methods, respectively. Serum PA levels were significantly lower in AFP-NHCC (84.5 ± 24.7 mg/L) than that in the controls (240.6 ± 59.4 mg/L, P < 0.05). For plasma fibrinogen levels, there was no difference between the controls (2.9 ± 0.7 g/L) and AFP-NHCC (2.5 ± 0.7 g/L). Compared with AFP-NHCC (0.8 ± 0.2 mg/L), plasma D-Dimer levels were significantly lower in controls (0.1 ± 0.0 mg/L, P < 0.05). The levels of PA, fibrinogen and D-Dimer were significantly correlated with differentiation (P < 0.01), and the PA and D-Dimer values were correlated with TNM stage (P < 0.05). Moreover, PA levels were correlated with tumor size (P = 0.034). Receiver operating characteristic curve (ROC) analyses elaborated that combination of PA, fibrinogen and D-Dimer possessed a higher sensitivity (93.4%) for differentiating AFP-NHCC from the controls, but the diagnostic specificity was reduced due to the combination of fibrinogen. After adjusting for all significant outcome predictors of the univariate logistic regression analysis, low levels of PA and high levels of D-Dimer were remained independent unfavorable outcome predictors (P < 0.05). Our data suggested that the expression levels of PA, fibrinogen and D-Dimer played critical roles in AFP-NHCC tumorigenesis. Moreover, PA and D-Dimer might be considered as potential diagnostic indicators in AFP-NHCC.
Similar content being viewed by others
References
Corwin MT, Lee AY, Fananapazir G, Loehfelm TW, Sarkar S, Sirlin CB (2018) Nonstandardized terminology to describe focal liver lesions in patients at risk for hepatocellular carcinoma: implications regarding clinical communication. AJR Am J Roentgenol 210(1):85–90. https://doi.org/10.2214/ajr.17.18416
Nadinskaia MY, Kodzoeva KB, Ulyanova KA, Volkova AS, Rogacheva SI, Dekhanov AS, Strelkova DA, Ivashkin VT (2019) Risk factors associated with portal vein thrombosis in liver cirrhosis: a case-control study. Terapevticheskii arkhiv 91(2):73–81. https://doi.org/10.26442/00403660.2019.02.000153
Monfardini L, Orsi F, Caserta R, Sallemi C, Della Vigna P, Bonomo G, Varano G, Solbiati L, Mauri G (2018) Ultrasound and cone beam CT fusion for liver ablation: technical note. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 35(1):500–504. https://doi.org/10.1080/02656736.2018.1509237
Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A (2016) The Doylestown algorithm: a test to improve the performance of AFP in the detection of hepatocellular carcinoma. Cancer Prev Res (Phila) 9(2):172–179. https://doi.org/10.1158/1940-6207.capr-15-0186
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP, Gao YF (2016) LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat Commun 7:12598. https://doi.org/10.1038/ncomms12598
Arbab K, Majid H, Jafri L, Akram B, Raheem A, Jamil B, Hashmi M, Khan AH (2019) Assessing nutritional status of critically ill patients using serum Prealbumin levels. J Ayub Med Coll, Abbottabad : JAMC 31(2):178–181
Wen X, Yao M, Lu Y, Chen J, Zhou J, Chen X, Zhang Y, Lu W, Qian X, Zhao J, Zhang L, Ding S, Lu F (2018) Integration of Prealbumin into child-Pugh classification improves prognosis predicting accuracy in HCC patients considering curative surgery. J Clin Transl Hepatol 6(4):377–384. https://doi.org/10.14218/jcth.2018.00004
Hou C, Jiang F, Ma H, Zhu Q, Wang Z, Zhao B, Xue T, Tan S, Yang R, Qian Y, Luo X, Zhao M, Xu X, Chen L, Li J (2019) Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: a multicenter prospective study. Thoracic Cancer 10(2):304–311. https://doi.org/10.1111/1759-7714.12956
Cai HX, Li XQ, Wang SF (2018) Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors. World J Gastroenterol 24(44):5046–5056. https://doi.org/10.3748/wjg.v24.i44.5046
Fan S, Zhao G, An G (2019) High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer. J Int Med Res 47(1):215–224. https://doi.org/10.1177/0300060518799869
Darweesh SK, Gad AA (2019) Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: efficacy, safety, and survival. Turk J Gastroenterol 30(5):445–453. https://doi.org/10.5152/tjg.2019.17191
Yamada R, Bassaco B, Bracewell S, Gillen K, Kocher M, Collins H, Anderson MB, Guimaraes M (2019) Long-term follow-up after conventional transarterial chemoembolization (c-TACE) with mitomycin for hepatocellular carcinoma (HCC). J Gastrointest Oncol 10(2):348–353. https://doi.org/10.21037/jgo.2019.01.01
Fung J, Cheung KS, Wong DK, Mak LY, To WP, Seto WK, Lai CL, Yuen MF (2018) Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance. Hepatology (Baltimore, Md) 68(2):462–472. https://doi.org/10.1002/hep.29874
Fan L, Chi C, Guo S, Wang Y, Cai W, Shao X, Xu F, Pan J, Zhu Y, Shangguan X, Xin Z, Hu J, Qian H, Xie S, Wang R, Zhou L, Dong B, Xue W (2017) Serum pre-albumin predicts the clinical outcome in metastatic castration-resistant prostate Cancer patients treated with Abiraterone. J Cancer 8(17):3448–3455. https://doi.org/10.7150/jca.21134
Braverman LE, Vagenakis A, Downs P, Foster AE, Sterling K, Ingbar SH (1973) Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest 52(5):1010–1017. https://doi.org/10.1172/jci107265
Yang F, Wei L, Huo X, Ding Y, Zhou X, Liu D (2018) Effects of early postoperative enteral nutrition versus usual care on serum albumin, prealbumin, transferrin, time to first flatus and postoperative hospital stay for patients with colorectal cancer: a systematic review and meta-analysis. Contemp Nurse 54(6):561–577. https://doi.org/10.1080/10376178.2018.1513809
Jia RR, Zhong JH, Huo RR, Su QB, Xiang X, Zhao FL, Qin ZB, Chen JH, Liao YY, Ma L, Xiang BD, Zhang CY, Li LQ (2019) Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy. J Surg Oncol 119(6):794–800. https://doi.org/10.1002/jso.25378
Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109(5):1971–1974. https://doi.org/10.1182/blood-2006-08-040956
Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3(8):1894–1904. https://doi.org/10.1111/j.1538-7836.2005.01365.x
Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, Ishigami S, Natsugoe S (2015) Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine 94(42):e1702. https://doi.org/10.1097/md.0000000000001702
Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, Kim SY, Park SC, Choi HS, Oh JH (2013) Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol 20(9):2908–2913. https://doi.org/10.1245/s10434-013-2968-8
Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G (2011) Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm 8(5):1538–1548. https://doi.org/10.1021/mp200137c
Zheng S, Shen J, Jiao Y, Liu Y, Zhang C, Wei M, Hao S, Zeng X (2009) Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci 100(5):859–865. https://doi.org/10.1111/j.1349-7006.2009.01115.x
Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, Thuren T (2012) Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 126(23):2739–2748. https://doi.org/10.1161/circulationaha.112.122556
Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887. https://doi.org/10.1182/blood-2008-06-165845
Man YN, Wang YN, Hao J, Liu X, Liu C, Zhu C, Wu XZ (2015) Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. Int J Gynecol Cancer 25(1):24–32. https://doi.org/10.1097/igc.0000000000000303
Batschauer AP, Figueiredo CP, Bueno EC, Ribeiro MA, Dusse LM, Fernandes AP, Gomes KB, Carvalho MG (2010) D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Ann Oncol 21(6):1267–1272. https://doi.org/10.1093/annonc/mdp474
Yamamoto M, Yoshinaga K, Matsuyama A, Iwasa T, Osoegawa A, Tsujita E, Yamashita Y, Tsutsui S, Ishida T (2012) Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. Oncology 83(1):10–15. https://doi.org/10.1159/000338329
Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F, Nakamura S, Yokoi K (2015) Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. Surg Today 45(1):63–67. https://doi.org/10.1007/s00595-014-0894-4
Liu P, Zhu Y, Liu L (2015) Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Onco Targets Ther 8:1335–1340. https://doi.org/10.2147/ott.s82329
Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW (2007) Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 5(Suppl 1):246–254. https://doi.org/10.1111/j.1538-7836.2007.02497.x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors have declared that no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jing, W., Peng, R., Zhu, M. et al. Differential Expression and Diagnostic Significance of Pre-Albumin, Fibrinogen Combined with D-Dimer in AFP-Negative Hepatocellular Carcinoma. Pathol. Oncol. Res. 26, 1669–1676 (2020). https://doi.org/10.1007/s12253-019-00752-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-019-00752-8